Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BRISBANE, Australia, July 05, 2021 (GLOBE NEWSWIRE) -- Galaxy Resources Limited (ASX: GXY) (Galaxy) and Orocobre Limited (ASX:ORE, TSX:ORL) (Orocobre) refer to the announcement made on 2 July 2021...
-
BRISBANE, Australia, July 04, 2021 (GLOBE NEWSWIRE) -- Galaxy Resources Limited (ASX: GXY) (Galaxy) and Orocobre Limited (ASX:ORE, TSX:ORL) (Orocobre) are pleased to provide an update on the...
-
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the...
-
Key highlights Ethics approval received for clinical trial in patients with diabetic foot ulcers First clinical trial to utilise the wound dressing technology recently licensed from TekCyte Patient...
-
VALENCIA, Calif. and MELBOURNE, Australia, June 29, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
-
TORONTO, June 29, 2021 (GLOBE NEWSWIRE) -- Northern Star Resources Ltd. (“Northern Star”) to file an early warning report (the “Early Warning Report”) advising of the sale of common shares (the...
-
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the Company or Macarthur) is pleased to advise that it has made an...
-
Industry’s first commercial integration of OTS selector with oxide-based ReRAMKey technology milestone achieved three months ahead of schedule HOD HASHARON, Israel, June 24, 2021 (GLOBE NEWSWIRE)...
-
VANCOUVER, British Columbia, June 22, 2021 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (TSX: NVO, NVO.WT & NVO.WT.A) (OTCQX: NSRPF) reports that all resolutions proposed...
-
MELBOURNE, Australia, June 22, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that a first patient has been dosed in a Phase I study of...